吡唑及其衍生物具有抗微生物、抗肿瘤、抗病毒、抗抑郁等药理活性，在吡唑上引入其他环状基团后可生成大量先导化合物，其中，环丙基的引入在药物分子发挥着多种作用：降低血浆清除率、降低脱靶作用、增加血脑屏障渗透率、增强对受体的亲和力、限制多肽的水解作用、改善药物的解离度。
Ethyl 1-cyclopropyl-3-methyl-1H-pyrazole-5-carboxylate
1-Cyclopropyl-1H-pyrazol-3-amine
1-Cyclopropyl-1H-pyrazole-3-carbaldehyde
3-Bromo-1-cyclopropyl-1H-pyrazole
1-Cyclopropyl-1H-pyrazole-5-carboxylic acid
1-Cyclopropyl-1H-pyrazole-4-carboxylic acid
5-Chloro-1-cyclopropyl-4-nitro-1H-pyrazole
1-Cyclopropyl-3-methyl-1h-pyrazol-5-amine
5-Bromo-1-cyclopropyl-1H-pyrazole
1-Cyclopropyl-1H-pyrazole-3-carboxylic acid
3-Chloro-6-(1-cyclopropyl-1H-pyrazol-4-yl)pyridazine
tert-Butyl (1-cyclopropyl-1H-pyrazol-3-yl)carbamate
1-Cyclopropyl-5-methyl-1H-pyrazol-3-amine
2-Chloro-4-((1-cyclopropyl-3-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl)oxy)pyridine
3-Chloro-1-cyclopropyl-pyrazole
1H-Pyrazol-4-amine, 1-cyclopropyl-, hydrochloride (1:2)
1-Cyclopropyl-1h-pyrazole-3-sulfonyl chloride
1-Cyclopropyl-4-methyl-1H-pyrazole
1-Cyclopropyl-3-nitro-1H-pyrazole
1-Cyclopropyl-4-fluoro-1H-pyrazole
